Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomized, double blind, parallel group, placebo controlled, multi center dose ranging study of solifenacin succinate in combination with tamsulosin hydrochloride compared with solifenacin succinate monotherapy and tamsulosin hydrochloride monotherapy in males with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)

Next Previous
X
Search
Trial Profile

A randomized, double blind, parallel group, placebo controlled, multi center dose ranging study of solifenacin succinate in combination with tamsulosin hydrochloride compared with solifenacin succinate monotherapy and tamsulosin hydrochloride monotherapy in males with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 04 Apr 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Solifenacin (Primary) ; Tamsulosin (Primary)
  • Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
  • Focus Therapeutic Use
  • Acronyms SATURN
  • Sponsors Astellas Pharma

    • Most Recent Events

    • 01 Aug 2012 New source identified and integrated (German Clinical Trials Register DRKS00004046).
    • 21 Jun 2012 Additional locations added as reported by European Clinical Trials Database record.
    • 10 Dec 2008 Actual patient number (919) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top